1. Home
  2. SEER vs VANI Comparison

SEER vs VANI Comparison

Compare SEER & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.68

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

HOLD

Current Price

$1.00

Market Cap

95.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
VANI
Founded
2017
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
95.8M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
SEER
VANI
Price
$1.68
$1.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
254.6K
201.3K
Earning Date
05-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
9.40
N/A
EPS
N/A
N/A
Revenue
$16,578,000.00
$4,000,000.00
Revenue This Year
$2.14
N/A
Revenue Next Year
$25.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.62
$0.91
52 Week High
$2.41
$1.92

Technical Indicators

Market Signals
Indicator
SEER
VANI
Relative Strength Index (RSI) 40.33 35.86
Support Level N/A N/A
Resistance Level $1.97 $1.26
Average True Range (ATR) 0.05 0.07
MACD -0.00 -0.02
Stochastic Oscillator 18.42 24.13

Price Performance

Historical Comparison
SEER
VANI

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

Share on Social Networks: